Adenomyoepitheliomatous lesions of the mammary glands in transgenic mice with targeted PLAG1 overexpression

International Journal of Cancer

Volumn 123, Issue 7, 2008, Pages 1593-1600

  Declercq, Jeroen ^a   Skaland, Ivar ^b,c   Van Dyck, Frederik ^a   Janssen, Emiel A M ^b   Baak, Jan P ^b,c,d   Drijkoningen, Maria ^e   Van De Ven, Wim J M ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b STAVANGER UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF BERGEN   (Norway)

^d VU UNIVERSITY AMSTERDAM   (Netherlands)

^e UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Cre mediated tumorigenesis; Mammary gland adenomyoepithelioma; PLAG1 proto oncogene; Transgenic mouse strains; Wnt signaling

Indexed keywords

CRE RECOMBINASE; SOMATOMEDIN; WNT PROTEIN; DNA BINDING PROTEIN; PLAG1 PROTEIN, MOUSE; PRIMER DNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CARCINOGENESIS; BREAST HYPERPLASIA; CONTROLLED STUDY; CYCLIN D1 GENE; DLK1 GENE; FEMALE; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE TARGETING; GTL2 GENE; H19 GENE; IGF2 GENE; IGFBP2 GENE; MAMMARY GLAND ADENOMYOEPITHELIOMA; MOUSE; MOUSE STRAIN; MYOEPITHELIOMA; NONHUMAN; ONCOGENE; PLAG1 GENE; PRIORITY JOURNAL; PROTO ONCOGENE; SALIVARY GLAND TUMOR; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; UPREGULATION; WNT6 GENE; ADENOMA; ANIMAL; EXPERIMENTAL NEOPLASM; GENETICS; IMMUNOHISTOCHEMISTRY; NUCLEOTIDE SEQUENCE; PATHOLOGY; POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ADENOMA; ANIMALS; BASE SEQUENCE; BLOTTING, WESTERN; DNA PRIMERS; DNA-BINDING PROTEINS; FEMALE; IMMUNOHISTOCHEMISTRY; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, TRANSGENIC; MYOEPITHELIOMA; POLYMERASE CHAIN REACTION;

EID: 50549083076     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.23586     Document Type: Article

References (32)

1. Kas K, Voz ML, Hensen K, Meyen E, Van de Ven WJ. Transcriptional activation capacity of the novel PLAG family of zinc finger proteins. J Biol Chem 1998;273:23026-32.
2. Braem CV, Kas K, Meyen E, Debiec-Rychter M, Van De Ven WJ, Voz ML. Identification of a karyopherin alpha 2 recognition site in PLAG1, which functions as a nuclear localization signal. J Biol Chem 2002;277:19673-8.
3. Voz ML, Agten NS, Van de Ven WJ, Kas K. PLAG1, the main translocation target in pleomorphic adenoma of the salivary glands, is a positive regulator of IGF-II. Cancer Res 2000;60:106-13.
4. Van Dyck F, Declercq J, Braem CV, Van de Ven WJ. PLAG1, the prototype of the PLAG gene family: versatility in tumour development (Review). Int J Oncol 2007;30:765-74.
5. Van Dyck F, Delvaux ELD, Van de Ven WJM, Chavez MV. Repression of the transactivating capacity of the oncoprotein PLAG1 by SUMOylation. J Biol Chem 2004;279:36121-31.
6. Zheng G, Yang YC. Sumoylation and acetylation play opposite roles in the transactivation of PLAG1 and PLAGL2. J Biol Chem 2005;280:40773-81.
7. Kas K, Voz ML, Roijer E, Astrom AK, Meyen E, Stenman G, Van de Ven WJ. Promoter swapping between the genes for a novel zinc finger protein and beta-catenin in pleomorphic adenomas with t(3;8) (p21;q12) translocations. Nat Genet 1997;15:170-4.
8. Voz ML, Astrom AK, Kas K, Mark J, Stenman G, Van de Ven WJ. The recurrent translocation t(5;8)(p13;q12) in pleomorphic adenomas results in upregulation of PLAG1 gene expression under control of the LIFR promoter. Oncogene 1998;16:1409-16.
9. Astrom A, D'Amore ES, Sainati L, Panarello C, Morerio C, Mark J, Stenman G. Evidence of involvement of the PLAG1 gene in lipoblastomas. Int J Oncol 2000;16:1107-10.
10. Hibbard MK, Kozakewich HP, Dal Cin P, Sciot R, Tan X, Xiao S, Fletcher JA. PLAG1 fusion oncogenes in lipoblastoma. Cancer Res 2000;60:4869-72.
11. Morerio C, Rapella A, Rosanda C, Tassano E, Gambini C, Romagnoli G, Panarello C. PLAG1-HAS2 fusion in lipoblastoma with masked 8q intrachromosomal rearrangement. Cancer Genet Cytogenet 2005;156:183-4.
12. Zatkova A, Rouillard JM, Hartmann W, Lamb BJ, Kuick R, Eckart M, von Schweinitz D, Koch A, Fonatsch C, Pietsch T, Hanash SM, Wimmer K. Amplification and overexpression of the IGF2 regulator PLAG1 in hepatoblastoma. Genes Chromosomes Cancer 2004;39:126-37.
13. Castilla LH, Perrat P, Martinez NJ, Landrette SF, Keys R, Oikemus S, Flanegan J, Heilman S, Garrett L, Dutra A, Anderson S, Pihan GA, et al. Identification of genes that synergize with Cbfb-MYH11 in the pathogenesis of acute myeloid leukemia. Proc Natl Acad Sci USA 2004;101:4924-9.
14. Landrette SF, Kuo YH, Hensen K, Barjesteh van Waalwijk van Doorn-Khosrovani S, Perrat PN, Van de Ven WJ, Delwel R, Castilla LH. Plag1 and Plag12 are oncogenes that induce acute myeloid leukemia in cooperation with Cbfb-MYH11. Blood 2005;105:2900-7.
15. Hensen K, Van Valckenborgh IC, Kas K, Van de Ven WJ, Voz ML. The tumorigenic diversity of the three PLAG family members is associated with different DNA binding capacities. Cancer Res 2002;62:1510-7.
16. Declercq J, Van Dyck F, Braem CV, Van Valckenborgh IC, Voz M, Wassef M, Schoonjans L, Van Damme B, Fiette L, Van de Ven WJ. Salivary gland tumors in transgenic mice with targeted PLAG1 protooncogene overexpression. Cancer Res 2005;65:4544-53.
17. Zhao X, Ren W, Yang W, Wang Y, Kong H, Wang L, Yan L, Xu G, Fei J, Fu J, Zhang C, Wang Z. Wnt pathway is involved in pleomorphic adenomas induced by overexpression of PLAG1 in transgenic mice. Int J Cancer 2006;118:643-8.
18. Wagner KU, McAllister K, Ward T, Davis B, Wiseman R, Hennighausen L. Spatial and temporal expression of the Cre gene under the control of the MMTV-LTR in different lines of transgenic mice. Transgenic Res 2001;10:545-53.
19. Wagner KU, Wall RJ, St-Onge L, Grass P, Wynshaw-Boris A, Garrett L, Li M, Furth PA, Hennighausen L. Cre-mediated gene deletion in the mammary gland. Nucleic Acids Res 1997;25:4323-30.
20. Matulka LA, Triplett AA, Wagner KU. Parity-induced mammary epithelial cells are multipotent and express cell surface markers associated with stem cells. Dev Biol 2007;303:29-44.
21. Kruse AJ, Skaland I, Janssen EA, Buhr-Wildhagen S, Klos J, Arends MJ, Baak JP. Quantitative molecular parameters to identify low-risk and high-risk early CIN lesions: role of markers of proliferative activity and differentiation and Rb availability. Int J Gynecol Pathol 2004;23:100-9.
22. Cleynen I, Huysmans C, Sasazuki T, Shirasawa S, Van de Ven W, Peeters K. Transcriptional control of the human high mobility group A1 gene: basal and oncogenic Ras-regulated expression. Cancer Res 2007;67:4620-9.
23. Tavassoli FA, Soares J. Myoepithelial lesions. In: Tavassoli FA, Devilee P, eds. WHO classification of tumours: pathology and genetics of tumours of the breast and female genital organs. Lyon: IARC Press, 2003.
24. Voz ML, Mathys J, Hensen K, Pendeville H, Van Valckenborgh I, Van Huffel C, Chavez M, Van Damme B, De Moor B, Moreau Y, Van de Ven WJ. Microarray screening for target genes of the protooncogene PLAG1. Oncogene 2004;23:179-91.
25. Janssens N, Janicot M, Perera T, Bakker A. Housekeeping genes as internal standards in cancer research. Mol Diagn 2004;8:107-13.
26. Sakatani T, Kaneda A, Iacobuzio-Donahue CA, Carter MG, de Boom Witzel S, Okano H, Ko MS, Ohlsson R, Longo DL, Feinberg AP. Loss of imprinting of Igf2 alters intestinal maturation and tumorigenesis in mice. Science 2005;307:1976-8.
27. Turashvili G, Bouchai J, Burkadze G, Kolar Z. Wnt signaling pathway in mammary gland development and carcinogenesis. Pathobiology 2006;73:213-23.
28. Benhaj K, Akcali KC, Ozturk M. Redundant expression of canonical Wnt ligands in human breast cancer cell lines. Oncol Rep 2006;15:701-7.
29. van Noort M, Meeldijk J, van der Zee R, Destree O, Clevers H. Wnt signaling controls the phosphorylation status of beta-catenin. J Biol Chem 2002;277:17901-5.
30. Babinet C. Transgenic mice: an irreplaceable tool for the study of mammalian development and biology. J Am Soc Nephrol 2000;11:S88-94.
31. Queimado L, Obeso D, Hatfield MD, Yang Y, Thompson DM, Reis AM. Dysregulation of Wnt pathway components in human salivary gland tumors. Arch Otolaryngol Head Neck Surg 2008;134:94-101.
32. Giles RH, van Es JH, Clevers H. Caught up in a Wnt storm: Wnt signaling in cancer. Biochim Biophys Acta 2003;1653:1-24.